Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 1/20 | 0.33 |
| ▸ | ADH1B | P00325 | 3/20 | 0.32 |
| ▸ | ADH1A | P07327 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ADH1C | P00326 | 2/20 | 0.30 |
| ▸ | ADH7 | P40394 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6764272 | 1.00 | CTRB1 (0.33) | CTRB1ADH1BADH1AALDH1A1TSHR | |
| SCHEMBL10816103 | 0.81 | CTRB1 (0.35) | CTRB1 | |
| SCHEMBL17074053 | 0.79 | ADH1B (0.34) | CTRB1ADH1BADH1ATSHRADH1C | |
| SCHEMBL11126612 | 0.74 | CTRB1 (0.31) | CTRB1 | |
| SCHEMBL16142754 | 0.73 | — | — | |
| SCHEMBL9060305 | 0.73 | — | — | |
| SCHEMBL14867596 | 0.73 | — | — | |
| SCHEMBL11795515 | 0.69 | ALOX15 (0.36) | — | |
| SCHEMBL7191306 | 0.68 | ALDH1A1 (0.30) | ALDH1A1TSHR | |
| SCHEMBL8634789 | 0.68 | CTRB1 (0.35) | CTRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709778-A1 | PROCESSES FOR PREPARING A MIXTURE THAT CONTAINS A POLYOXYALKYLENE POLYOL | Covestro Deutschland AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024231371-A1 | PROCESSES FOR PREPARING A MIXTURE THAT CONTAINS A POLYOXYALKYLENE POLYOL | COVESTRO DEUTSCHLAND AG (DE) | 2024-11-14 | — | — | WO | disclosed |
| EP-4461762-A1 | METHOD FOR PRODUCING A MIXTURE CONTAINING A POLYOXYALKYLENE POLYOL; MIXTURE AND COMPONENTS OBTAINED FROM THE METHOD | Covestro Deutschland AG (DE) | 2024-11-13 | — | — | EP | disclosed |
| US-12060454-B2 | Process for the continuous production of polyoxyalkylene polyols | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2024-08-13 | — | — | US | disclosed |
| EP-4114881-B1 | METHOD FOR PRODUCING AN ETHER ESTOL | COVESTRO DEUTSCHLAND AG (DE) | 2024-01-31 | — | — | EP | disclosed |
| EP-4180474-A1 | METHOD FOR THE PREPARATION OF POLYETHER CARBONATE ALCOHOLS | Covestro Deutschland AG (DE) | 2023-05-17 | — | — | EP | disclosed |
| EP-3717537-B1 | REACTION SYSTEM FOR A 1K-POLYURETHANE FOAM | COVESTRO DEUTSCHLAND AG (DE) | 2023-04-19 | — | — | EP | disclosed |
| US-20230086177-A1 | PROCESS FOR PREPARING POLYETHER CARBONATE POLYOLS | COVESTRO DEUTSCHLAND AG (DE) | 2023-03-23 | — | — | US | disclosed |
| EP-3980480-B1 | METHOD FOR CONTINUOUS PRODUCTION OF POLYOXYALKYLENPOLYOLS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-03-22 | — | — | EP | disclosed |
| US-20230070697-A1 | PROCESS FOR PRODUCING AN ETHER ESTEROL | COVESTRO DEUTSCHLAND AG (DE) | 2023-03-09 | — | — | US | disclosed |
| EP-1390358-A4 | AMINO ACID DERIVATIVES OF TRIPTOLIDE COMPOUNDS AS IMMUNE MODULATORS AND ANTICANCER AGENT | PHARMAGENESIS INC (US) | 2004-06-16 | — | — | EP | disclosed |
| US-6730289-B2 | HAIR STYLING MIXTURE COMPRISING AN ACYLATED CARBAMATE GROUP MODIFIED POLYURETHANE AND ACCEPTABLE CARRIER OR DILUENT; NO DEPOSITS ON HAIR, WATER SOLUBLE | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-05-04 | — | — | US | disclosed |
| EP-1390358-A1 | AMINO ACID DERIVATIVES OF TRIPTOLIDE COMPOUNDS AS IMMUNE MODULATORS AND ANTICANCER AGENT | PHARMAGENESIS, INC. (US) | 2004-02-25 | — | — | EP | disclosed |
| US-6569893-B2 | Administering to a patient a triptolide or its derivatives, containing an amino acid or oligopeptide moiety for the treatment of cancer and autoimmune deseases, or inhibition of transplant rejection, graft versus host disease | PHARMAGENESIS, INC. | 2003-05-27 | — | — | US | disclosed |
| US-20020193419-A1 | Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents | PHARMAGENESIS, INC. | 2002-12-19 | — | — | US | disclosed |
| US-20020176837-A1 | Cosmetic composition | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-11-28 | — | — | US | disclosed |
| WO-2002074759-A1 | AMINO ACID DERIVATIVES OF TRIPTOLIDE COMPOUNDS AS IMMUNE MODULATORS AND ANTICANCER AGENT | PHARMAGENESIS, INC. (US) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002058645-A1 | POLYURETHANES, COSMETIC COMPOSITIONS CONTAINING THEM AND METHOD OF PREPARATION | UNILEVER PLC (GB) | 2002-08-01 | — | — | WO | disclosed |
| US-6376151-B1 | HYDROXYPOLYAMIDES | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2002-04-23 | — | — | US | disclosed |
| EP-1096316-A1 | POSITIVE RESIST COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2001-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020176837-A1 | Cosmetic composition | POLR1C, ALKBH5, HAT1 | CTRB1 2640/4885ADH1B 3167/4885ADH1A 3063/4885 |
| US-20020193419-A1 | Amino acid derivatives of triptolide compounds as immune modulators and anticancer agents | CCRL2, CCR1, XPNPEP1 | CTRB1 1072/4885ADH1B 4574/4885ADH1A 4756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.